PPD Contract Research Facility Awarded Licenses by Irish Medicines Board

PPD has announced that its contract research facility in Athlone, Ireland, has been awarded manufacturer licenses by the Irish Medicines Board (IMB). The licenses support investigational medicinal products and marketed products and provide laboratory certifications for quality control of medicinal products.

PPD opened the facility in response to growing client demand from clients in Europe, Middle East and Africa for current Good Manufacturing Practice (cGMP) analytical testing services. The facility includes an 18,000-square-foot cGMP analytical testing laboratory and clinical supplies business.

The facility will offer fully integrated product and analytical development services, including method development; validation; stability, release and quality control testing; and global clinical supplies services, including secondary packing, labeling and storage. The facility will also provide regulatory services, product licensing and marketed product support, including Qualified Person (QP) services for all drug dosage forms.